Skip to content

Comparison of the effect of misoprostol and oxytocin on the induction of labor.

Comparison of the effect of misoprostol and oxytocin for the induction of labor in order to terminate pregnancy on maternal and fetal factors in pregnant women.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150407021653N18
Enrollment
90
Registered
2019-05-25
Start date
2019-06-22
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of termination of pregnancy on maternal and fetal factors.

Interventions

Intervention 1: Control group: As the control group, the physiological delivery is considered. Intervention 2: Intervention group1: receive misoprostol at a dose of 25 micrograms? during delivery. Int

Sponsors

Jahrom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Pregnant women aged 20-35 Women with a term of pregnancy> 37 weeks Lack of Contraindication for normal delivery Lack of drug sensitivity to misoprostol and oxytocin Lack of chronic diseases

Exclusion criteria

Exclusion criteria: Dissatisfaction of participants to attend the study Tearing membranes Limit of fetal growth

Design outcomes

Primary

MeasureTime frame
Frequency of fetal heart rate drop. Timepoint: End of labor after intervention. Method of measurement: By scoring the Apgar.;Average score of the Apgar. Timepoint: End of labor after intervention. Method of measurement: By scoring the Apgar.

Secondary

MeasureTime frame
Length of latent phase of labor. Timepoint: From the beginning of labor pain to the end of labor. Method of measurement: In minutes.;Duration of active phase of labor. Timepoint: From the 5-3 cm cervical dilatation to the end of pregnancy. Method of measurement: In minutes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAthar Rasekh Jahromi

Jahrom University of Medical Sciences

Drrasek@yahoo.com+98 71 5422 1040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026